Clinical Trial Update: A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

View source ↗

Summary

This entry reports a clinical trial evaluating tildrakizumab for genital psoriasis is currently recruiting. The sponsor listed is Almirall.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Genital Psoriasis | Status: RECRUITING